/PRNewswire/ Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), announced today that the company is postponing the start of the live-streamed R&D event on.
/PRNewswire/ Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), announced today that the company invites investors, analysts, and media to a live-streamed.
/PRNewswire/ Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL) ("Isofol"), will publish the company s results for the first quarter of 2022 on Thursday,.
/PRNewswire/ Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced the start of data analysis of the multi-center, global Phase III AGENT.
/PRNewswire/ Isofol Medical AB (publ) (Nasdaq Stockholm: ISOFOL), today announced the start of data analysis of the multi-center, global Phase III AGENT.